[The new possibility of therapy for medical personnel with metabolic syndrome].

[The new possibility of therapy for medical personnel with metabolic syndrome].

Meditsina truda i promyshlennaia ekologiia (2013-06-22)

P A Bakumov, E A Zerniukova, E R Grechkina

ABSTRACT

The possibility of magnesium deficiency correction was investigated in medical personnel with metabolic syndrome. It was shown that treatment with drugs containing magnesium leads to a decrease the cholesterol level.

MATERIALS

Product Number

Brand

Product Description

S5442

Sigma-Aldrich

SyntheChol^® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture

47127-U

Supelco

Cholesterol solution, certified reference material, 10 mg/mL in chloroform

723320

Sigma-Aldrich

Magnesium, in a Sure/Seal^™ bottle, turnings, anhydrous tetrahydrofuran 37.5 mmol

403148

Sigma-Aldrich

Magnesium, turnings, 5-25 mm, 99.95% trace metals basis

14606

Sigma-Aldrich

Cholesterol, tested according to Ph. Eur.

C3045

Sigma-Aldrich

Cholesterol, powder, BioReagent, suitable for cell culture, ≥99%

C8667

Sigma-Aldrich

Cholesterol, Sigma Grade, ≥99%

C8503

Sigma-Aldrich

Cholesterol, from sheep wool, ≥92.5% (GC), powder